Selective drug discovery collaborations giving pharma and academic partners access to Beactica's platform expertise.
Drug Discovery Partnerships are selective external collaborations through which pharmaceutical, biotechnology, and academic partners leverage Beactica's molecular interaction-based discovery platform and targeted protein degradation expertise.
Current collaborations include the GLIOBREAK project with KU Leuven funded by a EUR 2.5 million European Innovation Council grant and a preclinical evaluation collaboration with NIH/NCATS for TEAD degraders. Historic partner programmes contributed to regulatory approvals and outlicensing deals, including work with Janssen, Boehringer Ingelheim, and Sanofi.
Charles River Laboratories
Integrated Drug Discovery and Development
criver.com
Pharmaron
Integrated Drug Discovery and Development
pharmaron.com
Jubilant Biosys
Integrated Drug Discovery Services
jubilantbiosys.com
Adds products that compete with one of Drug Discovery Partnerships’ direct competitors but not with Drug Discovery Partnerships itself. They are shaded, and Linked Through names the direct competitor each one competes with.
| Attribute | Drug Discovery Partnerships | Integrated Drug Discovery and Development | Integrated Drug Discovery and Development | Integrated Drug Discovery Services | |
|---|---|---|---|---|---|
| Provider | | |  |  | |
| Founded | 2006 | 1947 | — | 1998 | |
| Sells To | Businesses | Enterprise, Small Business | — | Enterprise | |
| Pricing Model | Pre-Revenue | Recurring, Transactional | — | — | |
| Ownership | Private | Public | — | Public |
Provider
Founded 2006
Sells To Businesses
Pricing Model Pre-Revenue
Ownership Private
Provider
Founded 1947
Sells To Enterprise, Small Business
Pricing Model Recurring, Transactional
Ownership Public
Provider
Founded —
Sells To —
Pricing Model —
Ownership —
Provider
Founded 1998
Sells To Enterprise
Pricing Model —
Ownership Public
Drug discovery consulting services of transMedChem Consulting, spanning target validation through candidate identification.
Preclinical drug development consulting service of Alacrita, covering discovery support through candidate selection.
Drug discovery consulting services of transMedChem Consulting, spanning target validation through candidate identification.
Preclinical drug development consulting service of Alacrita, covering discovery support through candidate selection.